Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS)
CNY 16.74
(-0.71%)
CNY 16.74
(-0.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -164.25 Million | 2.75 Billion | 1.32 Billion | 1.95 Billion | 2.62 Billion | 2.05 Billion |
| Net Income | 318.97 Million | -1.71 Billion | 1.23 Billion | 1.84 Billion | 1.96 Billion | 1.9 Billion |
| Depreciation & Amortization | 599.35 Million | 497.56 Million | 510.43 Million | 424.54 Million | 386.08 Million | 371.9 Million |
| Deferred income taxes | -143.8 Million | -19.4 Million | -41.24 Million | 15.4 Million | -76.15 Million | -37.2 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.59 Billion | 675.49 Million | -651.7 Million | -422.91 Million | 236.04 Million | -276.2 Million |
| Other non-cash items | 3.45 Billion | 3.3 Billion | 226.36 Million | 113.98 Million | 35.97 Million | 47.64 Million |
| Investing Cash Flow | -195.05 Million | -1.01 Billion | -655.67 Million | -421.71 Million | -1.27 Billion | -1.59 Billion |
| Investments in PPE | -529.91 Million | -543.16 Million | -433.53 Million | -536.43 Million | -662.11 Million | -1.3 Billion |
| Acquisitions | 6.48 Million | -15.81 Million | -22.13 Million | 21.66 Million | -20.26 Million | - |
| Investment purchases | -71.63 Million | -478.96 Million | -50.5 Million | -24.9 Million | -11.92 Million | -475.51 Million |
| Sales/Maturities of investments | 400 Million | 10.86 Million | 78.51 Million | 24.61 Million | 38.75 Million | 93.37 Million |
| Other Investing Activities | 19.36 Million | 16.9 Million | -228 Million | 93.35 Million | -614.63 Million | 95 Million |
| Financing Cash Flow | -1.06 Billion | -987.56 Million | -770.88 Million | -1.88 Billion | -1.22 Billion | -938.97 Million |
| Debt repayment | -158.18 Million | -2.7 Billion | -3.13 Billion | -2.43 Billion | -1.79 Billion | -2.44 Billion |
| Dividends payments | -1.06 Billion | -398.17 Million | -581.77 Million | -1.78 Billion | -1.37 Billion | -1.18 Billion |
| Common Stock Repurchased | -9.98 Million | - | - | - | -740 Million | -200.01 Million |
| Common Stock Issuance | - | - | - | - | 740 Million | - |
| Other Financing Activities | -138.98 Million | 2.26 Billion | 3.11 Billion | 3.03 Billion | 1.48 Billion | 2.68 Billion |
| Accounts receivables | 83.67 Million | 483.36 Million | 363.13 Million | -648.66 Million | 640.33 Million | -175.55 Million |
| Accounts payables | -493.59 Million | 172.01 Million | 92.53 Million | 1.05 Billion | 209.77 Million | -135.93 Million |
| Inventory | -1.18 Billion | 39.52 Million | -1.06 Billion | -847.77 Million | -537.91 Million | 72.49 Million |
| Other working capital | -637.39 Million | -19.4 Million | -41.24 Million | 15.4 Million | -76.15 Million | -348.69 Million |
| Cash at beginning of period | 2.14 Billion | 1.36 Billion | 1.46 Billion | 1.81 Billion | 1.69 Billion | 2.17 Billion |
| Cash at end of period | 694.13 Million | 2.12 Billion | 1.36 Billion | 1.46 Billion | 1.81 Billion | 1.69 Billion |
| Capital Expenditure | -529.91 Million | -543.16 Million | -433.53 Million | -536.43 Million | -662.11 Million | -1.3 Billion |
| Effect of forex changes on cash | 9833.51 | 161.06 Thousand | -343.48 Thousand | -14.38 Thousand | 3587.26 | 57.44 Thousand |
| Net cash flow / Change in cash | -1.45 Billion | 758.04 Million | -106.38 Million | -348.95 Million | 125.54 Million | -485.04 Million |
| Free Cash Flow | -694.17 Million | 2.21 Billion | 886.97 Million | 1.42 Billion | 1.95 Billion | 741 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 81.44 Million | 117.4 Million | 114.01 Million | 318.97 Million | -606.17 Million | 179 Million |
| Depreciation & Amortization | - | 153.51 Million | 153.51 Million | 599.35 Million | 151.33 Million | -213.59 Million |
| Deferred income taxes | - | - | - | -143.8 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -1.59 Billion | -1.1 Billion | 357.2 Million |
| Other non-cash items | 121.66 Million | 462.78 Million | -39.9 Million | 3.45 Billion | 992.33 Million | -1 Billion |
| Investing Cash Flow | -50.3 Million | -56.86 Million | -84.2 Million | -195.05 Million | -143.56 Million | -83.31 Million |
| Investments in PPE | -54.83 Million | -46.82 Million | -87.32 Million | -529.91 Million | -143.85 Million | -136.78 Million |
| Acquisitions | 14.36 Million | 4.61 Million | 2.21 Million | 6.48 Million | 3.16 Million | 1.57 Million |
| Investment purchases | - | -13.75 Million | - | -71.63 Million | -4.13 Million | -37.5 Million |
| Sales/Maturities of investments | - | - | - | 400 Million | 20 Million | 383.38 Million |
| Other Investing Activities | 4.52 Million | 2.67 Million | 909.07 Thousand | 19.36 Million | -18.74 Million | -293.99 Million |
| Financing Cash Flow | -457.39 Million | -121.59 Million | 330.29 Million | -1.06 Billion | 127.26 Million | -1.23 Billion |
| Debt repayment | -74.87 Million | -192.34 Million | -537.31 Million | -158.18 Million | -80.48 Million | -438.02 Million |
| Dividends payments | -169.82 Million | -35.76 Million | -33.43 Million | -1.06 Billion | -1.06 Billion | -1.1 Billion |
| Common Stock Repurchased | 422.38 Million | -422.38 Million | - | -9.98 Million | -9.98 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -212.69 Million | 138.77 Million | -207.01 Million | -138.98 Million | 1.13 Billion | 305.41 Million |
| Accounts receivables | - | - | - | 83.67 Million | 83.67 Million | 183.62 Million |
| Accounts payables | - | - | - | -493.59 Million | - | - |
| Inventory | - | - | - | -1.18 Billion | -1.18 Billion | 173.57 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.26 Billion | 1.01 Billion | 694.13 Million | 2.14 Billion | 558.83 Million | 2.47 Billion |
| Cash at end of period | 957.3 Million | 1.26 Billion | 1.01 Billion | 694.13 Million | 694.13 Million | 473.81 Million |
| Capital Expenditure | -54.83 Million | -46.82 Million | -87.32 Million | -529.91 Million | -143.85 Million | -136.78 Million |
| Effect of forex changes on cash | -6981.21 | 25.86 Thousand | -21.28 Thousand | 9833.51 | -8455.76 | -2309.84 |
| Net cash flow / Change in cash | -303.44 Million | 248.98 Million | 319.44 Million | -1.45 Billion | 135.29 Million | -2 Billion |
| Free Cash Flow | 148.28 Million | 379.84 Million | -13.21 Million | -694.17 Million | 90.97 Million | -816.44 Million |
AAUGF
CMRB
7038
IRS-WT
BAMBINO
NHCFOODS